Paper359336
The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
Fevrier M and 4 others. Eur J Immunol, 1978. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide. Papers, record 359336. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/359336
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylmuramyl-Alanyl-Isoglutamine | Major topic |
| Adjuvants, Immunologic | Major topic |
| Glycopeptides | Major topic |
| Macrophages | Major topic |
| Animals | |
| Antigens | |
| Cells, Cultured | |
| Erythrocytes | |
| Hemolytic Plaque Technique | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA | |
| Muramic Acids | |
| Polysaccharides, Bacterial | |
| Sheep | |
| Spleen |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36848790 | Highlights into historical and current immune interventions for cancer. | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/36848790 | PubMed |
| 36013944 | Regulation of Immune Homeostasis via Muramyl Peptides-Low Molecular Weight Bioregulators of Bacterial Origin. | Microorganisms | 2022 | https://conductscience.org/library/papers/36013944 | PubMed |
| 28026115 | Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery. | Small | 2017 | https://conductscience.org/library/papers/28026115 | PubMed |
| 26565602 | Roles and relevance of mast cells in infection and vaccination. | J Biomed Res | 2016 | https://conductscience.org/library/papers/26565602 | PubMed |
| 17422948 | Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium. | Can Vet J | 1988 | https://conductscience.org/library/papers/17422948 | PubMed |
| 7439991 | Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice. | Infect Immun | 1980 | https://conductscience.org/library/papers/7439991 | PubMed |
| 7216470 | Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice. | Infect Immun | 1981 | https://conductscience.org/library/papers/7216470 | PubMed |
| 7061099 | Regulation of secondary antibody responses in rodents. II. The requirement for continued antigen supply to maintain IgG production. | Immunology | 1982 | https://conductscience.org/library/papers/7061099 | PubMed |
| 7035868 | Muramyl peptides. Chemical structure, biological activity and mechanism of action. | Mol Cell Biochem | 1981 | https://conductscience.org/library/papers/7035868 | PubMed |
| 6982864 | In vitro studies on the adjuvanticity of Brucella fractions. | Infect Immun | 1982 | https://conductscience.org/library/papers/6982864 | PubMed |
| 6979042 | In vivo immune response to a T-cell-dependent antigen by cultures of disassociated murine Peyer's patch. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6979042 | PubMed |
| 6840853 | Effective immunity to dental caries: enhancement of salivary anti-Streptococcus mutans antibody responses with oral adjuvants. | Infect Immun | 1983 | https://conductscience.org/library/papers/6840853 | PubMed |
| 6767407 | Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP). | Am J Pathol | 1980 | https://conductscience.org/library/papers/6767407 | PubMed |
| 6743532 | Enhancement of the local inflammatory response to bacterial infection by muramyl dipeptide. | Br J Exp Pathol | 1984 | https://conductscience.org/library/papers/6743532 | PubMed |
| 6437984 | Processing of Bacillus subtilis peptidoglycan by a mouse macrophage cell line. | Infect Immun | 1984 | https://conductscience.org/library/papers/6437984 | PubMed |
| 6334022 | Accelerated expansion of antibody heterogeneity by complete Freund's adjuvant during the response to bacterial alpha-amylase. | Immunology | 1984 | https://conductscience.org/library/papers/6334022 | PubMed |
| 6187686 | Enhancement of antigen-specific suppression by muramyl dipeptide. | Infect Immun | 1983 | https://conductscience.org/library/papers/6187686 | PubMed |
| 3988341 | Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. | Infect Immun | 1985 | https://conductscience.org/library/papers/3988341 | PubMed |
| 2187809 | Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection. | Infect Immun | 1990 | https://conductscience.org/library/papers/2187809 | PubMed |
| 478648 | Macrophage activation by bacterial cell walls and related synthetic compounds. | Infect Immun | 1979 | https://conductscience.org/library/papers/478648 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/359336
GET https://conductscience.org/api/papers/v1/359336/cited_by?page=2